Radiopharmaceutical firm Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, will use Eczacıbaşı-Monrol Nuclear Products of Gebze, Turkey, to expand into the Balkans, Middle East, North Africa, and central and eastern Europe.
IBA has signed an agreement for Eczacıbaşı-Monrol to distribute and market IBA's PET and SPECT radiopharmaceuticals in those regions.
Eczacıbaşı-Monrol also plans to invest in three more FDG-PET production centers to complement its existing network of five cyclotrons.
Related Reading
IBA gets FDA nod for pencil-beam scanning, December 19, 2008
IBA opens Dallas PET facility, December 17, 2008
IBA responds to FDA warning letter, December 11, 2008
IBA opens production center in Dallas, December 2, 2008
IBA signs deal with Biotech Cyclotron, December 1, 2008
Copyright © 2009 AuntMinnie.com
